Skip to main content

Table 1 Baseline Patient Characteristics

From: Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

 

Urethral Sparing IMRT

Standard IMRT

Total Cohort

# of patients

8

8

16

Age (mean ± SD)

63.9 ± 7.3

64.5 ± 7.1

64.21 ± 6.9

Pretreatment PSA (ng/mL)

8.1 ± 1.3

7.4 ± 1.5

7.74 ± 0.62

# positive cores (mean ± SD)

1.6 ± 0.7

1.1 ± 0.4

1.4 ± 0.6

EPIC Urinary Domain Summary score (mean ± SD)

86.9 ± 13.4

81.6 ± 16.5

84.3 ± 14.8

EPIC Bowel Domain Summary score (mean ± SD)

96.6 ± 5.1

92.5 ± 7.1

94.5 ± 6.4

EPIC Sexual Domain Summary score (mean ± SD)

52.5 ± 12.4

47.4 ± 32.8

50.0 ± 24.1

EPIC Hormonal Domain Summary score (mean ± SD)

89.3 ± 15.3

90.6 ± 9.8

90.0 ± 12.4

Satisfaction Score (mean ± SD)

85.7 ± 19.7

85.0 ± 13.7

85.4 ± 16.7